Neural Therapy in Cesareans

Not yet recruitingOBSERVATIONAL
Enrollment

156

Participants

Timeline

Start Date

June 10, 2025

Primary Completion Date

September 10, 2025

Study Completion Date

October 10, 2025

Conditions
Visual Analogue Scale
Interventions
DRUG

neural therapy

This prospective study will be conducted with mothers who underwent general anesthesia for labor or elective cesarean delivery and local anesthesia for postoperative pain management during a one-year period following ethical approval.

All Listed Sponsors
lead

Haseki Training and Research Hospital

OTHER

NCT06999200 - Neural Therapy in Cesareans | Biotech Hunter | Biotech Hunter